A nanoconstruct (NC) is developed from a biocompatible natural polymer and siRNA conjugates to deliver small interfering RNA (siRNA) target-specifically without cationic condensation reagents. This study reports a novel siRNA-mediated cross-linked NC produced by hybridizing two complementary single-stranded siRNAs that are conjugated to the polymer dextran via a disulfide linkage. The reducible disulfide bond between the siRNA and polymer allow siRNA release from the NC in the reducible cytoplasmic region after the NC enters the cell. In addition, when the NC contains the prostate-carcinoma-binding peptide aptamer DUP-1, it can selectively deliver siRNA into prostate cancer cells of the PC-3 lines; thus, the newly formulated NC has reduced ...
siRNA and microRNA are promising therapeutic agents, which are engaged in a natural mechanism called...
For systemic delivery of siRNA to solid tumors, a size-regulated and reversibly stabilized nanoarchi...
Clinical translation of polymer-based nanocarriers for systemic delivery of RNA has been limited due...
siRNA (small interfering RNA), which interferes with gene expression by inhibiting the production of...
Small interfering RNA (siRNA) is receiving increasing attention with regard to the treatment of many...
International audienceThe application of small interfering RNA (siRNA) cancer therapeutics is limite...
Success of synthetic interfering nucleic acids (siRNAs)-based therapy relies almost exclusively on e...
Cancer is one of the most common causes of death worldwide. Two types of cancer that have high morta...
siRNA nanomedicines can potentially treat many human diseases, but safe and effective delivery remai...
The delivery of small interfering RNA (siRNA) remains a major hurdle for the clinical translation of...
peer reviewedPolyplexes are nanoparticles composed of small-interfering RNA (siRNA) and natural or s...
The lack of safe and efficient gene delivery system limits the efforts to develop new RNA drugs to c...
siRNA (small interfering RNA), which interferes with gene expression by inhibiting the production of...
The lack of safe and efficient gene delivery system limits the efforts to develop new RNA drugs to c...
Small interfering RNA (siRNA) represent an interesting class of developmental nucleic acid-based the...
siRNA and microRNA are promising therapeutic agents, which are engaged in a natural mechanism called...
For systemic delivery of siRNA to solid tumors, a size-regulated and reversibly stabilized nanoarchi...
Clinical translation of polymer-based nanocarriers for systemic delivery of RNA has been limited due...
siRNA (small interfering RNA), which interferes with gene expression by inhibiting the production of...
Small interfering RNA (siRNA) is receiving increasing attention with regard to the treatment of many...
International audienceThe application of small interfering RNA (siRNA) cancer therapeutics is limite...
Success of synthetic interfering nucleic acids (siRNAs)-based therapy relies almost exclusively on e...
Cancer is one of the most common causes of death worldwide. Two types of cancer that have high morta...
siRNA nanomedicines can potentially treat many human diseases, but safe and effective delivery remai...
The delivery of small interfering RNA (siRNA) remains a major hurdle for the clinical translation of...
peer reviewedPolyplexes are nanoparticles composed of small-interfering RNA (siRNA) and natural or s...
The lack of safe and efficient gene delivery system limits the efforts to develop new RNA drugs to c...
siRNA (small interfering RNA), which interferes with gene expression by inhibiting the production of...
The lack of safe and efficient gene delivery system limits the efforts to develop new RNA drugs to c...
Small interfering RNA (siRNA) represent an interesting class of developmental nucleic acid-based the...
siRNA and microRNA are promising therapeutic agents, which are engaged in a natural mechanism called...
For systemic delivery of siRNA to solid tumors, a size-regulated and reversibly stabilized nanoarchi...
Clinical translation of polymer-based nanocarriers for systemic delivery of RNA has been limited due...